Annual CFF
$191.24 M
+$116.87 M+157.16%
December 31, 2024
Summary
- As of March 9, 2025, RYTM annual cash flow from financing activities is $191.24 million, with the most recent change of +$116.87 million (+157.16%) on December 31, 2024.
- During the last 3 years, RYTM annual CFF has risen by +$24.76 million (+14.87%).
- RYTM annual CFF is now -10.56% below its all-time high of $213.83 million, reached on December 31, 2022.
Performance
RYTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$38.33 M
+$35.84 M+1438.04%
December 31, 2024
Summary
- As of March 9, 2025, RYTM quarterly cash flow from financing activities is $38.33 million, with the most recent change of +$35.84 million (+1438.04%) on December 31, 2024.
- Over the past year, RYTM quarterly CFF has increased by +$35.84 million (+1438.04%).
- RYTM quarterly CFF is now -76.85% below its all-time high of $165.59 million, reached on March 31, 2021.
Performance
RYTM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$191.24 M
+$35.91 M+23.11%
December 31, 2024
Summary
- As of March 9, 2025, RYTM TTM cash flow from financing activities is $191.24 million, with the most recent change of +$35.91 million (+23.11%) on December 31, 2024.
- Over the past year, RYTM TTM CFF has increased by +$35.91 million (+23.11%).
- RYTM TTM CFF is now -38.35% below its all-time high of $310.18 million, reached on June 30, 2018.
Performance
RYTM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RYTM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +157.2% | +1438.0% | +23.1% |
| 3 y3 years | +14.9% | +10000.0% | +14.9% |
| 5 y5 years | +17.0% | +10000.0% | +14.9% |
RYTM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.6% | +157.2% | -75.8% | +4071.8% | -15.3% | >+9999.0% |
| 5 y | 5-year | -10.6% | +9419.3% | -76.8% | +4071.8% | -15.3% | >+9999.0% |
| alltime | all time | -10.6% | -100.0% | -76.8% | +4071.8% | -38.4% | >+9999.0% |
Rhythm Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $191.24 M(+157.2%) | $38.33 M(+1438.0%) | $191.24 M(+23.1%) |
| Sep 2024 | - | $2.49 M(-98.3%) | $155.34 M(-31.2%) |
| Jun 2024 | - | $146.18 M(+3345.2%) | $225.89 M(+186.9%) |
| Mar 2024 | - | $4.24 M(+75.1%) | $78.74 M(+5.9%) |
| Dec 2023 | $74.37 M(-65.2%) | $2.42 M(-96.7%) | $74.37 M(-16.7%) |
| Sep 2023 | - | $73.04 M(-7669.2%) | $89.31 M(-48.9%) |
| Jun 2023 | - | -$965.00 K(+625.6%) | $174.83 M(-18.0%) |
| Mar 2023 | - | -$133.00 K(-100.8%) | $213.30 M(-0.2%) |
| Dec 2022 | $213.83 M(+28.4%) | $17.36 M(-89.0%) | $213.83 M(+8.8%) |
| Sep 2022 | - | $158.56 M(+322.8%) | $196.56 M(+411.7%) |
| Jun 2022 | - | $37.50 M(+9298.5%) | $38.41 M(+2866.2%) |
| Mar 2022 | - | $399.00 K(+299.0%) | $1.29 M(-99.2%) |
| Dec 2021 | $166.48 M(+8186.8%) | $100.00 K(-75.8%) | $166.48 M(-0.2%) |
| Sep 2021 | - | $413.00 K(+7.8%) | $166.80 M(-0.2%) |
| Jun 2021 | - | $383.00 K(-99.8%) | $167.09 M(+0.1%) |
| Mar 2021 | - | $165.59 M(>+9900.0%) | $166.89 M(+8207.0%) |
| Dec 2020 | $2.01 M | $420.00 K(-39.9%) | $2.01 M(-98.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $699.00 K(+282.0%) | $163.55 M(+0.0%) |
| Jun 2020 | - | $183.00 K(-74.1%) | $163.55 M(-0.2%) |
| Mar 2020 | - | $707.00 K(-99.6%) | $163.87 M(+0.2%) |
| Dec 2019 | $163.47 M(-0.7%) | $161.96 M(>+9900.0%) | $163.47 M(+9724.2%) |
| Sep 2019 | - | $697.00 K(+40.0%) | $1.66 M(-22.2%) |
| Jun 2019 | - | $498.00 K(+57.6%) | $2.14 M(-98.7%) |
| Mar 2019 | - | $316.00 K(+106.5%) | $165.00 M(+0.2%) |
| Dec 2018 | $164.69 M(-1.5%) | $153.00 K(-87.0%) | $164.69 M(-43.2%) |
| Sep 2018 | - | $1.17 M(-99.3%) | $290.19 M(-6.4%) |
| Jun 2018 | - | $163.36 M(>+9900.0%) | $310.18 M(+111.3%) |
| Mar 2018 | - | $0.00(-100.0%) | $146.82 M(-12.2%) |
| Dec 2017 | $167.20 M(>+9900.0%) | $125.66 M(+493.7%) | $167.20 M(+302.5%) |
| Sep 2017 | - | $21.16 M(>+9900.0%) | $41.54 M(+103.9%) |
| Jun 2017 | - | $0.00(-100.0%) | $20.38 M(0.0%) |
| Mar 2017 | - | $20.38 M | $20.38 M |
| Dec 2016 | $0.00(-100.0%) | - | - |
| Dec 2015 | $41.71 M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual CFF year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly CFF year-on-year change?
- What is Rhythm Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM CFF year-on-year change?
What is Rhythm Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of RYTM is $191.24 M
What is the all time high annual CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash flow from financing activities is $213.83 M
What is Rhythm Pharmaceuticals annual CFF year-on-year change?
Over the past year, RYTM annual cash flow from financing activities has changed by +$116.87 M (+157.16%)
What is Rhythm Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of RYTM is $38.33 M
What is the all time high quarterly CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash flow from financing activities is $165.59 M
What is Rhythm Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, RYTM quarterly cash flow from financing activities has changed by +$35.84 M (+1438.04%)
What is Rhythm Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of RYTM is $191.24 M
What is the all time high TTM CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM cash flow from financing activities is $310.18 M
What is Rhythm Pharmaceuticals TTM CFF year-on-year change?
Over the past year, RYTM TTM cash flow from financing activities has changed by +$35.91 M (+23.11%)